Literature DB >> 32566234

Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.

E H Awoyelu1, E K Oladipo2, B O Adetuyi1, T Y Senbadejo3, O M Oyawoye2, J K Oloke1.   

Abstract

Phyloepidemiological approaches have provided specific insight into understanding the emergence and evolution of infection. Knowledge on the outbreak and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Nigeria would assist in provision of preventive measures to reduce transmission among populations at risk. This study aimed to investigate the evolution of SARS-CoV-2 in Nigeria. A total of 39 complete genomes of SARS-CoV-2 were retrieved from the GISAID EpiFlu™ database on 29 March 2020 to investigate its evolution in Nigeria. Sequences were selected based on the travel history of the individual and the collection date. Other sequences were not selected because they were short, contained artefacts, were not from an original source or had insufficient information. Evolutionary history was inferred using the maximum likelihood method based on the general time reversible model. A phylogenetic tree was constructed to determine the common ancestor of each strain. The phylogenetic analysis showed that the strain in Nigeria clustered in a monophyletic clade with a Wuhan sublineage. Nucleotide alignment also showed a 100% similarity indicating a common origin of evolution. Comparative analysis showed 27 972 (93.6%) identical sites and 97.6% pairwise identity with the consensus. The study evidently showed the entire outbreak of SARS-CoV-2 infection in Nigeria stemmed from a single introduction sharing consensus similarity with the reference SARS-CoV-2 human genome from Wuhan. Preventive measures that can limit the spread of the infection among populations at risk should be implemented.
© 2020 Published by Elsevier Ltd.

Entities:  

Keywords:  Evolutionary analysis; Nigeria; preventive measures; severe acute respiratory syndrome coronavirus 2; transmission chain

Year:  2020        PMID: 32566234      PMCID: PMC7293838          DOI: 10.1016/j.nmni.2020.100717

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


Introduction

The first confirmed case of coronavirus disease 2019 (COVID-19) in Nigeria was announced on 27 February 2020, when an infected traveller from one of the WHO-identified high-risk countries—Italy—arrived by commercial aircraft into Lagos. Although, the traveller's movement was restricted, another positive case was reported in Ewekoro, Ogun State, a Nigerian citizen who had had contact with the Italian citizen. Despite lockdown in some states and several precautionary measures put in place to prevent and contain the spread of the disease, the Nigeria Centre for Disease Control has since reported over 400 cases of infected individuals with 17 deaths in about 20 States. Incidences of emerging/re-emerging viral infections have significantly affected human health despite extraordinary progress in the area of biomedical knowledge [1]. The key to understanding this emergence and evolution of novel viruses is subject to knowledge of the intricate host–pathogen–environment relationship [2]. Understanding the modes of transmission of an emerging infectious disease continues to be a key factor in implementing effective public health measures [3]. Proper tracking of genome sequences has helped to ensure optimal virus diagnostic tests, tracking and tracing of the ongoing outbreak and proper identification of potential intervention options [4]. Reports have suggested the route of transmission to be airborne [5], or via direct contact, droplets and transmission from mildly ill or asymptomatic individuals [6,7]. However, lack of evidence on transmission dynamics can lead to inconsistencies in the isolation guidelines. Phyloepidemiological approaches have given specific insight into understanding the emergence and evolution of emerging and re-emerging viruses, particularly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [8]. Knowledge on the outbreak and spread of SARS-CoV-2 in Nigeria would help in providing preventive measures and reducing transmission among populations at risk. Hence, this study aimed to investigate the evolution of SARS-CoV-2 in Nigeria.

Methods

Nucleotide sequence retrieval and alignment tool

A total of 39 complete genomes (Table 1) of novel SARS-CoV-2 were retrieved from the GISAID database (https://www.epicov.org) on 29 March 2020. Sequences retrieved include those from China, Italy, France, Nigeria, South Africa and Congo.
Table 1

Characteristics of the 40 SARS-CoV-2 genomic sequences used in this study

CountryAccession numberMonth/year of collectionAge (year)Sex
NigeriaEPI_ISL_41355002/202044M
CongoEPI_ISL_41795003/202048M
EPI_ISL_41744203/202039F
EPI_ISL_41743603/202043M
South AfricaEPI_ISL_41718603/202038M
FranceEPI_ISL_40659601/202031F
EPI_ISL_40843101/202053M
EPI_ISL_41122001/202030F
EPI_ISL_41072001/202031F
EPI_ISL_41048602/202056F
EPI_ISL_41462302/202036M
EPI_ISL_41462402/2020
EPI_ISL_41462602/202088F
EPI_ISL_41650202/202070
EPI_ISL_41462502/202059F
EPI_ISL_41674903/202044F
EPI_ISL_41674603/202061M
EPI_ISL_41675103/202016M
EPI_ISL_41675603/202088F
EPI_ISL_41675203/202049F
ChinaEPI_ISL_40211912/201949F
EPI_ISL_40212312/201965M
EPI_ISL_40392912/201952F
EPI_ISL_40212412/201949F
EPI_ISL_40671601/2020
EPI_ISL_40897802/202065F
EPI_ISL_40851402/2020
EPI_ISL_41298202/2020M
ItalyEPI_ISL_41348903/202038F
EPI_ISL_41792103/202032M
EPI_ISL_41792202/202041M
EPI_ISL_41792303/202053M
EPI_ISL_41297402/202057M
EPI_ISL_41297302/202038M
EPI_ISL_41742101/202045M
EPI_ISL_41054501/202066F
EPI_ISL_41297401/202057M
EPI_ISL_41749103/202075M
Characteristics of the 40 SARS-CoV-2 genomic sequences used in this study Sequences were selected based on the travel history of the patient and the collection date. The sequences were then aligned to obtain the conserved regions using multiple sequence alignment with the aid of Clustal W on Mega X [[15], [16], [17]].

Evolution analysis

The sequences were subjected to evolutionary divergence analysis. The phylogenetic tree was constructed to determine the common ancestor of each strain using MEGA 5.2 [[18], [19], [20]]. Comparative analysis of strains within clades was performed on Geneious Prime (https://www.geneious.com/) based on statistical analysis to determine positions in the genomic sequences from Nigeria that significantly differ from other strains.

Results

Evolutionary history

The analysis involved 39 nucleotide sequences. The evolutionary history was inferred using a maximum likelihood method based on the general time reversible model. The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analysed. Branches corresponding to partitions reproduced in <50% of bootstrap replicates were collapsed. Initial tree(s) for the heuristic search were obtained automatically by applying neighbour-joining and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite likelihood approach, and then selecting the topology with superior log likelihood value. A discrete gamma distribution was used to model evolutionary rate differences among sites (five categories (+G, parameter = 200.0000)). The rate variation model allowed for some sites to be evolutionarily invariable ((+I), 0.0000% sites). Codon positions included were 1st+2nd+3rd + Noncoding. All positions containing gaps and missing data were eliminated. There was a total of 25 459 positions in the final data set. The maximum likelihood tree is shown in Fig. 1.
Fig. 1

Maximum Likelihood Tree of SARS-CoV-2. Sequences were aligned using MAFFT and tree reconstruction using MEGA 5.0.

Maximum Likelihood Tree of SARS-CoV-2. Sequences were aligned using MAFFT and tree reconstruction using MEGA 5.0. Multiple sequence alignment using ClustalW (https://www.ebi.ac.uk/Tools/services/rest/muscle), showed that all the genomes that formed a clade with the strain from Nigeria generally had more than 70% similarity in the genetic sequence.

Conserved variants

Fig. 2(a–g) showed consensus similarities and variants between three strains from Wuhan, China and Nigeria, including the reference human SARS-CoV-2 genome. Sequences in the alignment were compared to the consensus to identify polymorphisms. At each position, the consensus is the allele with frequency >50%. N is ambiguity if no allele exceeds 50%.
Fig. 2

(a–f) Consensus variants between the four strains studied; (g) consensus variants showing gaps in the genomic sequence from Nigeria.

(a–f) Consensus variants between the four strains studied; (g) consensus variants showing gaps in the genomic sequence from Nigeria.

Discussion

Knowledge on the transmission chain of an emerging or re-emerging virus combined with sequence data provide more insight into explaining occurrence of mutation and spread of infection [9]. In the Nigerian COVID-19 outbreak, viewed by itself, Nigerian sequence data submitted by Okwuraiwe et al. [10] have provided a clear picture that the entire outbreak stemmed from a single introduction into the country. This is an indication that the first case is an imported case that has turned into a serious health challenge in society. Along with the somewhat close proximity of the sample collection dates to each other, it is possible to reconstruct a transmission chain and infer that the patient from Nigeria contracted the virus through a patient who became infected with the Wuhan strain, as seen from the phylogenetic tree. The two strains are in the same clade by sharing the genetic information. The reconstruction can be explained through the findings of Parvez and Parveen [1] that the emergence of infectious diseases in naive regions is dependent on the movement of pathogens via trade and travel, whereas local emergence is driven by a combination of environmental and social changes [11]. Multiple sequence alignment separated the strains studied into three distinct clades depending on their divergence from their common ancestor. The strains from Wuhan further subdivided the clades into three subclades. The strain from Nigeria was found in the Wuhan subclade 3 together with some strains from Congo and France. The strains that formed a monophyletic clade with Wuhan subclade 3 resembled the genetic sequence with >70% similarity. More importantly, the tree confirmed that the outbreak in Nigeria was the result of a single introduction from China/Wuhan through an imported case of an Italian. More specifically, the imported SARS-CoV-2 strain from Nigeria is a descendant of the China/Wuhan strain as also described by Zhu et al. [12]. Comparative analysis of the strain from Nigeria, two strains from Wuhan sharing the same clade and the reference human SARS-CoV-2 genome was performed. Results from Geneious Prime showed that all four sequences had 27 972 (93.6%) identical sites and 97.6% pairwise identity. The strain from Nigeria and Wuhan strain (WH05/2020) had more genome sequence similarity compared with strain WH01/2020. They shared consensus similarity with the reference SARS-CoV-2 human genome, showing a common descendant as observed from other studies [13,14]. The strain imported into Nigeria by the Italian shared <20% variant characteristics with Wuhan strain WH01/2020. Compared with the consensus, the strain from Nigeria had 49 gaps, 39 unknowns and seven point mutations. More than 80% of these differences were unique to Nigeria. In summary, on the basis of the evolutionary analysis, it is evident that human-to-human transmission occurred, hence preventive measures should be adhered to so as to control the spread of the virus. The study showed that the entire outbreak of COVID-19 infection in Nigeria stemmed from a single introduction sharing consensus similarity with the reference SARS-CoV-2 human genome from Wuhan. Establishment of the phyloevolutionary relationship of the Nigerian reference sequence for SARS-CoV-2 could benefit the biological study of this virus, and the diagnosis, clinical monitoring and intervention for SARS-CoV-2 infections in Nigeria.

Conflict of interest

The authors’ declare no conflict of interest.
  3 in total

Review 1.  COVID-19 in West Africa: regional resource mobilisation and allocation in the first year of the pandemic.

Authors:  Césaire Ahanhanzo; Ermel Ameswue Kpogbe Johnson; Ejemai Amaize Eboreime; Sombié Issiaka; Ben Idrissa Traoré; Clétus C Y Adohinzin; Tosin Adesina; Ely Noel Diallo; Nanlop Obgureke; Stanley Okolo
Journal:  BMJ Glob Health       Date:  2021-05

Review 2.  Consolidating and Upscaling Molecular Research Capacity in Nigeria: On Who's Account?

Authors:  Chinwe Uzoma Chukwudi
Journal:  Front Res Metr Anal       Date:  2022-01-05

3.  Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.

Authors:  Augustina Angelina Sylverken; Philip El-Duah; Michael Owusu; Julia Schneider; Richmond Yeboah; Nana Kwame Ayisi-Boateng; Richmond Gorman; Eric Adu; Alexander Kwarteng; Michael Frimpong; Tabea Binger; Sherihane Aryeetey; Jesse Addo Asamoah; Yaw Ampem Amoako; John Humphrey Amuasi; Jörn Beheim-Schwarzbach; Ellis Owusu-Dabo; Yaw Adu-Sarkodie; Kwasi Obiri-Danso; Victor Max Corman; Christian Drosten; Richard Phillips
Journal:  Arch Virol       Date:  2021-03-15       Impact factor: 2.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.